What Amai Proteins makes
Amai Proteins develops designer proteins for the mass food market, and its first product is a sweet protein, sold as sweelin, that reduces added sugar. Used at tiny doses as a sweetener rather than for nutrition, it belongs to the same family of fermentation-derived ingredients as precision-fermented whey and other proteins made by engineered microbes.
Naturally sweet proteins occur along the equatorial belt, according to the company. Earlier attempts to produce them at scale were hampered by low stability, high cost and a poor sensory profile. Amai says it redesigned such a protein with computational tools and produces it by precision fermentation, to match the taste of sugar at low cost.
The company states that sweelin is about 3,000 times sweeter than sugar, that a teaspoon of sugar can be replaced by roughly half a milligram of protein, and that it has zero calories. It says the protein is digested in the upper digestive tract and causes no sugar spike. These are company claims to check against the cited reports.
The Pro3 platform
Amai’s technology platform is called Pro3. It combines AI computational protein design, precision fermentation and food technology, and is organised around four goals named Pro-Taste, Pro-Planet, Pro-Health and Pro-Industry. The science page lists attributes such as taste, cost effectiveness, digestibility, sustainability, hypoallergenic character and stability to temperature, pH and fat.
A buyer should ask which production strain is used, what the fermentation scale is, whether the host is genetically modified, how the protein is purified and dried, and what residual host protein and nucleic acid remain. Those answers decide the allergen statement, the labelling and the regulatory file in each market, so they belong in the technical questionnaire.
The company gives a model: for each one percent decrease in worldwide sugar production, it says, about 1.72 million metric tons of sugar consumption could be avoided each year, along with savings of water and land. Those are modelled impact figures, not measurements of its own production, so treat them as scenario statements.
Uses and regulatory position
The home page lists soft drinks, fruit juices, dairy and alternative dairy, sauces, spreads, snacks, ketchup, chocolate, peanut butter, energy bars and functional foods as intended uses. Because the sweetener is used in milligram quantities, a developer will usually add a bulking ingredient to supply the volume, mouthfeel and browning that sugar normally provides.
The news page records milestones. A partnership with Ocean Spray on a cranberry juice with about 40 percent less sugar dates from December 2020, and a consortium with PepsiCo, Danone and the Technion followed in October 2022. A March 2025 paper in the Journal of Applied Toxicology reported full digestibility and no toxicity or mutagenicity.
Regulatory announcements start in October 2024 with multiple approvals, followed by a human clinical trial in December 2024 and a GRAS notification to the United States Food and Drug Administration in February 2026. The company says its studies showed no effect on blood glucose or insulin. Confirm the approval status in each target market before launch.
How a buyer would evaluate Amai
Start with the regulatory map. For each market, ask whether sweelin is authorised, which category and maximum level apply and what the labelling term is. The European Union needs a novel food authorisation for most precision fermentation products, whereas the United States uses the GRAS route and its notification letters.
Test the sweetness profile in the real recipe. The company lists stability to temperature, pH and fat as an attribute, so ask for the values. Run trials across the pH and heat treatment of the intended product, such as pasteurised juice or baked bars, and measure sweetness equivalence, aftertaste and storage stability by sensory panel and protein assay.
Finally, assess supply and cost. Ask for the production site, batch size, price per sweetness unit rather than per kilogram, lead time and the minimum order. Because the technology is new, request a written commitment on supply continuity, change notification for strain or process changes, and clarity on exclusivity if a partner funds application development for a specific product category.